Fusion Finance Limited (NSE:FUSION)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-12,245	5,053	3,872	217.55	439.44
Depreciation & Amortization	103.6	88.8	73.6	52.47	36.92
Other Amortization	13.1	1.3	0.5	1.24	2.02
Loss (Gain) From Sale of Investments	-1,665	-1,813	-1,248	-910.9	-295.6
Provision for Credit Losses	18,649	3,611	1,995	3,685	2,208
Stock-Based Compensation	128.9	131.1	67.2	39.24	30.4
Change in Accounts Payable	88.6	-39	439.6	63.6	72.36
Change in Other Net Operating Assets	8,728	-20,757	-21,969	-19,227	-10,056
Other Operating Activities	663	220.3	139.1	-327.91	-366.92
Operating Cash Flow	14,479	-13,503	-16,630	-16,407	-7,930
Capital Expenditures	-66.4	-163.9	-75.3	-62.77	-75.41
Sale of Property, Plant & Equipment	36.5	0.1	-	-	0.99
Sale (Purchase) of Intangibles	-38.6	-28.3	-	-0.05	-2.45
Investment in Securities	812.5	508	253.8	247.65	172.45
Other Investing Activities	-	-1.1	-	-	-
Investing Cash Flow	744	314.8	178.5	184.83	95.58
Long-Term Debt Issued	40,301	71,732	51,950	42,043	35,288
Long-Term Debt Repaid	-62,497	-53,366	-41,953	-28,518	-20,701
Net Debt Issued (Repaid)	-22,196	18,366	9,997	13,525	14,587
Issuance of Common Stock	56.9	66	5,845	660.89	4.79
Other Financing Activities	-	-	-	-3.94	-
Financing Cash Flow	-22,139	18,432	15,842	14,182	14,592
Net Cash Flow	-6,916	5,243	-610.1	-2,040	6,758
Free Cash Flow	14,412	-13,667	-16,706	-16,470	-8,006
Free Cash Flow Margin	-	-110.06%	-177.81%	-492.90%	-289.53%
Free Cash Flow Per Share	131.13	-135.55	-186.11	-199.83	-100.10
Cash Interest Paid	8,081	7,672	6,231	4,926	3,647
Cash Income Tax Paid	303.7	1,379	1,130	416.74	535.75

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.